Venous ulcers are a major problem, affecting around 1% of the adult population 1 and more than 3.6% of people aged over 65 years 2 . A population study in Scotland found that venous disease is a contributory factor in 76% of patients with leg ulcers 3 . The estimated cost of leg ulcers to the National Health Service is currently in excess of £600 million per year and leg ulceration also has a major impact on patients' quality of life, causing both pain and depression 4 . Because of these large financial and psychosocial costs it is important that the most clinically effective and cost-effective treatment is identified.
Venous ulceration occurs when high-pressure venous blood gravitates to the ankle due to disease in the superficial or deep venous system 5 . The latter may be due to a previous deep vein thrombosis or due to primary valve failure similar to that which occurs in the superficial system 6 . The risk of ulceration may be greater in patients with elevated ambulatory venous pressures, however the data available indicate a large degree of overlap and it is difficult to use as a discriminatory guide 6, 7 . Other contributory factors include minor trauma, oedema, obesity, arthritis and neuropathies 8 . Duplex scanning studies have shown that 75-92% of venous ulcer patients have superficial reflux, 43-92% have deep reflux and 8-57% have superficial reflux alone, i.e. variable patterns exist but there is a potentially high number of patients with surgically correctable superficial venous disease. Compression therapy has been regarded as the mainstay for ulcer healing, with a realistic success rate of about 60% 9 .
The applicability of surgery in terms of healing and recurrence has been disputed, with figures for healing and recurrence rates after surgical intervention varying from 52-100% and 0-32%, respectively. However, the results of two randomized trials have shown no benefit for surgery in terms of ulcer healing 1 0,11 . The larger ESCHAR study has, however, shown benefit in terms of recurrence rates at one-year follow up in those patients with superficial incompetence, and those with superficial and segmental deep vein incompetence. Therefore in terms of recurrence rates surgery has a proven benefit. It may therefore lead one to the proposition that surgery should only be offered to Editorial Surgery and the venous leg ulcer those patients whose ulcer has healed by compression. The benefit of adopting this strategy would be that potentially 'futile operations' could be avoided and venous investigation could be withheld until ulcer healing has occurred. These comments will be regarded as controversial and discussion is welcomed. What also has to be considered is the likelihood of an often elderly patient being prepared to accept a surgical therapy?
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